. However, OAC discontinuation doubled the risk for recurrent IS compared with those who continued on blood thinners, new research showed.
While previous studies have examined this increased risk prior to the index IS, few have specifically focused on OAC discontinuation and the risk for IS recurrence.
At 1 year, the crude cumulative incidence of recurrent IS and all-cause mortality were 4.3% and 15.4% , respectively. The researchers found similar results in the adjusted analyses." There was no information about the reasons patients discontinued OAC."Reasons underpinning OAC discontinuation are at present poorly understood," they wrote.